@jakeelberg.bsky.social of @setonhallhealthlaw.bsky.social moderating health law panel at “The End of Chevron Deference: Navigating Federal Admin Law in the Wake of Loper Bright” w/ Prof. Lewis Grossman of @auwcl.bsky.social, @christinasho.bsky.social, @medlawdan.bsky.social, @danielorr.bsky.social
@setonhallhealthlaw.bsky.social faculty are having a fantastic time at the Health Law Professors conference @bulaw.bsky.social! @jakeelberg.bsky.social @tararagone.bsky.social @dorfmandoron.bsky.social @kathleen-boozang.bsk.social Carl Coleman & Anjali Deshmukh
#HLP2025 #ASLME
Thrilled about the "ACA at 15" symposium by Seton Hall J of Legislation & @setonhallhealthlaw.bsky.social on March 14!
With @lindsaywiley.bsky.social @christinasho.bsky.social @weparmet.bsky.social @mblawrence.bsky.social @yaelcannon.bsky.social+other ⭐⭐⭐
Register: law.shu.edu/events/journ...!
Seton Hall Law Center for Health & Pharmaceutical Law
Tara Adams Ragone
Doron Dorfman
Congratulations to all of the Seton Hall Law School students graduating today, including the 15 students graduating with a Concentration in Health Law!
The Seton Hall Law Center for Health & Pharmaceutical Law is excited to be heading to Boston for the 2025 #HealthLaw Professors Conference! #HLPC25
In a new Forefront article, Prof. @jakeelberg.bsky.social, Glenn Cohen @petrieflomcenter.bsky.social, & Eli Adashi discuss the potential the Supreme Court will gut the False Claims Act's qui tam program, and the implications for health care fraud enforcement.
www.healthaffairs.org/content/fore...
Seton Hall Law Center for Health & Pharmaceutical Law
Seton Hall Law Center for Health & Pharmaceutical Law
www.healthaffairs.org
It is not clear what would become of the federal government’s health care enforcement efforts without the False Claims Act’s qui tam program.
Seton Hall Law Center for Health & Pharmaceutical Law
Seton Hall Law Center for Health & Pharmaceutical Law
Great time at ASLME #HLPC2025, hosted by @bulaw.bsky.social @busph.bsky.social last week!
Our panel on Direct-to-Prescription Pharmaceuticals (with @weparmet.bsky.social @cehaupt.bsky.social @jakeelberg.bsky.social) was well-attended despite being slotted in the last session of the conference.
It was a pleasure working with the editors of the Missouri Law Review to publish "Money Over Everything: Reimagining Health Care Enforcement": papers.ssrn.com/sol3/papers....
Proud to stand with more than 40 law professors from New Jersey law schools in an op-ed explaining why President Trump's interim appointment for U.S. Attorney is unqualified for the position.
www.law.com/njlawjournal...
papers.ssrn.com
Annual press releases from the Department of Justice trumpet billions of dollars in annual recoveries and optimism that its health care enforcement regime deter